Company intelligence / Profile preview

Recombine

Viçosa, Minas Gerais, Brazil

Ownership: Private
Development stage: Other

Overview

Recombine Biotech is a Brazilian R&D company leveraging recombinant technologies to develop biodefensives, vaccines, diagnostics, and detection systems for agriculture and animal health, with a focus on sustainability and productivity gains. Products are in development and validation, primarily targeting the agribusiness sector.

Therapeutic areas: OtherInfectious Diseases
Modalities: Recombinant proteinVaccineDiagnostic testBiodefensiveBiocoating
Industry: Agriculture & AgTech

Partnerships

Federal University of Viçosa (UFV)BiotechTown Innovation Hub Accelerator

Beyond the preview

Go deeper on Recombine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recombine.

Explore the full profile